Skip to content
MedsAcross

Medicine

Sertraline 20 mg/mL oral concentrate

Sertraline · Oral
Available on requestPrescription onlyUS FDAGeneric name

Sertraline 20 mg/mL oral concentrate is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25ºC (68º to 77ºF), excursions permitted to 15º to 30ºC (59°…

Key facts

Active ingredient (INN)
Sertraline
Brand
Sold under the generic name
Strength
20 mg/mL
Dosage form
Oral concentrate
Route
Oral
Packs
1 bottle and 1 more
Manufacturers
Aurobindo PharmaIndiaMylan PharmaceuticalsRising Pharma Holdings
Origin register
US FDA, United States
Storage
Store at 20º to 25ºC (68º to 77ºF), excursions permitted to 15º to 30ºC (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AB06 Sertraline
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
31 October 2008
Identifiers
RxCUI 861064DailyMed set ID af2c75a3-131e-4bde-83fd-310fd2c01161, 01800452-c353-4235-a66a-214048752e74, 1a58062b-e635-431a-908d-2651c6a4a21cNDC 64980-409, 65862-224, 59762-0067Application ANDA078861, NDA020990

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle, plastic in 1 carton / 60 mL in 1 bottle, plastic65862-224-20Aurobindo PharmaIndia31 October 2008
1 bottle in 1 carton / 60 mL in 1 bottle65862-224-60Aurobindo PharmaIndia31 October 2008
1 bottle, dropper in 1 carton / 60 mL in 1 bottle, dropper59762-0067-1Mylan Pharmaceuticals15 May 2018
1 bottle, plastic in 1 carton / 60 mL in 1 bottle, plastic64980-409-06Rising Pharma Holdings31 October 2008

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 December 1991Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Sertraline 20 mg/mL oral concentrate.

Compare 1

Other strengths and forms of Sertraline

Clinical summary

Sertraline is a serotonin reuptake inhibitor indicated for the treatment of the following, among other approved uses. It is available as tablets, capsules and oral concentrate. MedsAcross supplies Sertraline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sertraline

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sertraline 20 mg/mL oral concentrate for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.